Literature DB >> 1838188

The gastrointestinal tract in Down syndrome.

J Levy1.   

Abstract

Down Syndrome is recognized as one of the most common predisposing conditions for a group of serious gastrointestinal (GI) anomalies. Tracheo-esophageal fistula, duodenal obstruction with or without pyloric stenosis, annular pancreas, imperforate anus and Hirschsprung's disease are the most prevalent lesions. Understanding of the morphogenetic mechanisms responsible for this range of abnormalities is far from clear, as none of the lesions is specific to the trisomic state and the underlying defects (i.e., failure of foregut canalization, failure of neural crest cell migration into the myenteric and submucosal plexuses or malformation of the anterior abdominal wall, etc) are encountered in unaffected infants. Segregation analysis of inheritance patterns points to multi-factorial traits and random genetic action provide appropriate models (to a certain extent) for describing the observations. Furthermore, intestinal anomalies can be found in many other genetic disorders, with recent evidence suggesting the presence of GI developmental regulatory genes on chromosome 13q. A possible common pathway to the observed anomalies might be enhanced epithelial adhesiveness, as demonstrated in vitro experiments with fibroblasts. Molecular genetic techniques applied to the smallest human autosome could provide the needed insight into the ultimate mechanisms determining morphogenesis. The development of a murine model is a promising tool for the successful approach to these extraordinarily complex questions.

Entities:  

Mesh:

Year:  1991        PMID: 1838188

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  9 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

2.  Congenital duodenal stenosis and annular pancreas: a delayed diagnosis in an adolescent patient with Down syndrome.

Authors:  Alessandra Savino; Valeria Rollo; Francesco Chiarelli
Journal:  Eur J Pediatr       Date:  2006-10-17       Impact factor: 3.183

Review 3.  Advances in understanding the association between Down syndrome and Hirschsprung disease (DS-HSCR).

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2018-09-14       Impact factor: 1.827

4.  The development of colon innervation in trisomy 16 mice and Hirschsprung's disease.

Authors:  J C Li; K H Mi; J L Zhou; L Busch; W Kuhnel
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

5.  Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome.

Authors:  A Contestabile; T Fila; A Cappellini; R Bartesaghi; E Ciani
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

Review 6.  Down syndrome and the enteric nervous system.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2008-07-17       Impact factor: 1.827

7.  Screening for celiac disease in Down's syndrome patients revealed cases of subtotal villous atrophy without typical for celiac disease HLA-DQ and tissue transglutaminase antibodies.

Authors:  Oivi Uibo; Kaupo Teesalu; Kaja Metskula; Tiia Reimand; Riste Saat; Tarvo Sillat; Koit Reimand; Tiina Talvik; Raivo Uibo
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

8.  Treating acid reflux disease in patients with Down syndrome: pharmacological and physiological approaches.

Authors:  Francesco Macchini; Ernesto Leva; Maurizio Torricelli; Alberto Valadè
Journal:  Clin Exp Gastroenterol       Date:  2011-01-25

9.  Incarcerated paraesophageal hernia complicated by pancreatic damage and unusual comorbidity: Two retrospective case series.

Authors:  H M Haug; E Johnson; T Mala; D T Førland; T T Søvik; H O Johannessen
Journal:  Int J Surg Case Rep       Date:  2018-11-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.